• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cell-free DNA as an obesity biomarker.无细胞 DNA 作为肥胖生物标志物。
Physiol Res. 2020 Jul 16;69(3):515-520. doi: 10.33549/physiolres.934242. Epub 2020 May 29.
2
Effects of obesity, and of weight loss following bariatric surgery, on methylation of DNA from the rectal mucosa and in cell-free DNA from blood.肥胖症及减重手术对直肠黏膜 DNA 及血游离 DNA 甲基化的影响。
Int J Obes (Lond). 2023 Dec;47(12):1278-1285. doi: 10.1038/s41366-023-01384-4. Epub 2023 Sep 15.
3
High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy.血清中高浓度的C反应蛋白(CRP)预示着肥胖女性在接受袖状胃切除术后内脏脂肪会有益地减少。
Nutr Metab Cardiovasc Dis. 2018 May;28(5):494-500. doi: 10.1016/j.numecd.2018.01.014. Epub 2018 Feb 2.
4
Acute high-intensity interval exercise induces comparable levels of circulating cell-free DNA and Interleukin-6 in obese and normal-weight individuals.急性高强度间歇运动在肥胖者和正常体重者中诱导产生相当水平的循环无细胞 DNA 和白细胞介素 6。
Life Sci. 2018 Jun 1;202:161-166. doi: 10.1016/j.lfs.2018.04.007. Epub 2018 Apr 10.
5
Serum biomarkers of inflammation and adiposity in the LABS cohort: associations with metabolic disease and surgical outcomes.LABS 队列中炎症和肥胖的血清生物标志物:与代谢性疾病和手术结果的关联。
Int J Obes (Lond). 2019 Feb;43(2):285-296. doi: 10.1038/s41366-018-0088-z. Epub 2018 May 17.
6
Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy.循环游离 DNA:在放化疗期间区分炎症和感染的潜在生物标志物。
Radiother Oncol. 2018 Dec;129(3):575-581. doi: 10.1016/j.radonc.2018.07.016. Epub 2018 Aug 7.
7
Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery.游离DNA和降钙素原作为多发伤和大手术ICU患者并发症的早期标志物
Clin Lab. 2016 Dec 1;62(12):2395-2404. doi: 10.7754/Clin.Lab.2016.160615.
8
Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.Roux-en-Y 胃旁路术或袖状胃切除术前后血浆可溶性尿激酶型纤溶酶原激活物受体 (suPAR) 和高敏 C 反应蛋白水平:一项为期 1 年的前瞻性观察研究。
J Endocrinol Invest. 2021 Mar;44(3):599-608. doi: 10.1007/s40618-020-01358-7. Epub 2020 Jul 17.
9
C-reactive protein level in morbidly obese patients before and after bariatric surgery.肥胖症患者在减肥手术前后的C反应蛋白水平。
Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):90-5. doi: 10.1016/j.rgmx.2013.11.002. Epub 2014 May 27.
10
Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery.在接受减重和代谢手术的患者队列中,代谢转变先于炎症的解决。
Sci Rep. 2021 Jun 9;11(1):12127. doi: 10.1038/s41598-021-91393-y.

引用本文的文献

1
Circulating Cell-Free DNA in Metabolic Diseases.代谢性疾病中的循环游离DNA
J Endocr Soc. 2025 Jan 15;9(2):bvaf006. doi: 10.1210/jendso/bvaf006. eCollection 2025 Jan 6.
2
Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure.新冠肺炎呼吸衰竭患者循环游离 DNA 水平升高。
Sci Rep. 2024 Jul 29;14(1):17399. doi: 10.1038/s41598-024-68433-4.
3
Regulation of Cathelicidin Antimicrobial Peptide (CAMP) Gene Expression by TNFα and cfDNA in Adipocytes.脂肪细胞中 TNFα 和 cfDNA 对防御素抗菌肽 (CAMP) 基因表达的调控。
Int J Mol Sci. 2023 Oct 31;24(21):15820. doi: 10.3390/ijms242115820.
4
Effect of Bariatric Surgery on Plasma Cell-Free Mitochondrial DNA, Insulin Sensitivity and Metabolic Changes in Obese Patients.减肥手术对肥胖患者血浆游离线粒体DNA、胰岛素敏感性及代谢变化的影响。
Biomedicines. 2023 Sep 12;11(9):2514. doi: 10.3390/biomedicines11092514.
5
Nanopore sequencing reveals methylation changes associated with obesity in circulating cell-free DNA from Göttingen Minipigs.纳米孔测序揭示了哥廷根小型猪循环无细胞 DNA 中与肥胖相关的甲基化变化。
Epigenetics. 2023 Dec;18(1):2199374. doi: 10.1080/15592294.2023.2199374.
6
Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors.游离DNA在非感染性炎症和肿瘤发病机制及治疗中的作用
Biomedicines. 2022 Nov 8;10(11):2853. doi: 10.3390/biomedicines10112853.
7
Cell-Free DNA: Potential Application in COVID-19 Diagnostics and Management.无细胞游离 DNA:在 COVID-19 诊断和管理中的潜在应用。
Viruses. 2022 Feb 4;14(2):321. doi: 10.3390/v14020321.
8
Sex Difference in Plasma Deoxyribonuclease Activity in Rats.大鼠血浆脱氧核糖核酸酶活性的性别差异。
Physiol Res. 2021 Dec 30;70(6):913-920. doi: 10.33549/physiolres.934766. Epub 2021 Oct 30.
9
Properties and Application of Cell-Free DNA as a Clinical Biomarker.无细胞 DNA 的特性及其作为临床生物标志物的应用。
Int J Mol Sci. 2021 Aug 24;22(17):9110. doi: 10.3390/ijms22179110.

本文引用的文献

1
Obesity: global epidemiology and pathogenesis.肥胖症:全球流行病学和发病机制。
Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8.
2
High levels of circulating cell-free DNA are a biomarker of active SLE.循环游离 DNA 水平升高是 SLE 活动的生物标志物。
Eur J Clin Invest. 2018 Nov;48(11):e13015. doi: 10.1111/eci.13015. Epub 2018 Aug 23.
3
Acute high-intensity interval exercise induces comparable levels of circulating cell-free DNA and Interleukin-6 in obese and normal-weight individuals.急性高强度间歇运动在肥胖者和正常体重者中诱导产生相当水平的循环无细胞 DNA 和白细胞介素 6。
Life Sci. 2018 Jun 1;202:161-166. doi: 10.1016/j.lfs.2018.04.007. Epub 2018 Apr 10.
4
A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.使用游离细胞 DNA 进行癌症诊断的现场指南:从原理到实践及临床应用。
Genes Chromosomes Cancer. 2018 Mar;57(3):123-139. doi: 10.1002/gcc.22517. Epub 2017 Dec 20.
5
Cell-Free DNA as an Earlier Predictor of Exercise-Induced Performance Decrement Related to Muscle Damage.无细胞游离 DNA 作为运动引起的肌肉损伤相关运动表现下降的早期预测指标。
Int J Sports Physiol Perform. 2018 Aug 1;13(7):953-956. doi: 10.1123/ijspp.2017-0421. Epub 2018 Jul 28.
6
Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.亚临床炎症性肥胖的预测因素:瘦素、极低密度脂蛋白胆固醇血浆水平及CD16⁺单核细胞的CD14表达
Obes Facts. 2017;10(4):308-322. doi: 10.1159/000464294. Epub 2017 Jul 22.
7
Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.肥胖诱导的脂肪细胞释放的 DNA 会刺激慢性脂肪组织炎症和胰岛素抵抗。
Sci Adv. 2016 Mar 25;2(3):e1501332. doi: 10.1126/sciadv.1501332. eCollection 2016 Mar.
8
New obesity classification criteria as a tool for bariatric surgery indication.作为减肥手术指征工具的新肥胖分类标准。
World J Gastroenterol. 2016 Jan 14;22(2):681-703. doi: 10.3748/wjg.v22.i2.681.
9
The aetiology of obesity beyond eating more and exercising less.肥胖的病因并非仅仅是吃得更多和运动得更少。
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):533-44. doi: 10.1016/j.bpg.2014.07.001. Epub 2014 Jul 11.
10
Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment.脓毒症的生物标志物及其在诊断、预后和治疗中的潜在价值。
Expert Rev Clin Immunol. 2014 Oct;10(10):1349-56. doi: 10.1586/1744666X.2014.949675. Epub 2014 Aug 21.

无细胞 DNA 作为肥胖生物标志物。

Cell-free DNA as an obesity biomarker.

机构信息

Department of Physiological Sciences, Health Sciences Center, Federal University of Espírito Santo, Vitória, Brazil.

出版信息

Physiol Res. 2020 Jul 16;69(3):515-520. doi: 10.33549/physiolres.934242. Epub 2020 May 29.

DOI:10.33549/physiolres.934242
PMID:32469237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8648313/
Abstract

Obesity is a disease that affects about 13 % of the world population (2016) (Who 2018). This condition generates a process of systemic inflammation that may contribute to the release of cell-free DNA (cfDNA) into the bloodstream. cfDNA has been considered a potential biomarker to monitor several physiological and pathological conditions, such as tumors, exercise intensity and obesity. Therefore, the objective of this study was to evaluate the association of cfDNA levels with the amount of weight and fat mass lost six months after bariatric surgery. Thirty-eight subjects classified as obese (BMI, 43.5+/-6.2; BFP, 46.6+/-4.8) were evaluated anthropometrically and underwent bariatric surgery. Weight, BMI, body fat percentage (BFP), waist circumference, C-Reactive Protein (CRP) and cfDNA levels were evaluated before and six months after surgery; furthermore, a correlation was performed between cfDNA levels and BFP and CRP. Decrease in total body weight and CRP were observed after bariatric surgery; however, the cfDNA levels remained unchanged. There was a weak correlation between cfDNA levels and BFP before the bariatric surgery, and a moderate correlation between cfDNA and CRP. Obese subjects who underwent bariatric surgery, the decrease in body fat percentage did not result in changes in cfDNA levels six months after surgery.

摘要

肥胖是一种影响约 13%世界人口(2016 年)(世界卫生组织 2018 年)的疾病。这种情况会导致全身炎症过程,这可能导致游离细胞 DNA(cfDNA)释放到血液中。cfDNA 已被认为是监测多种生理和病理状况(如肿瘤、运动强度和肥胖)的潜在生物标志物。因此,本研究的目的是评估 cfDNA 水平与减肥手术后 6 个月体重和体脂量的关系。38 名肥胖受试者(BMI,43.5+/-6.2;BFP,46.6+/-4.8)进行了人体测量学评估,并接受了减肥手术。在手术前和手术后 6 个月评估体重、BMI、体脂百分比(BFP)、腰围、C-反应蛋白(CRP)和 cfDNA 水平;此外,还对 cfDNA 水平与 BFP 和 CRP 之间进行了相关性分析。减肥手术后体重和 CRP 均下降;然而,cfDNA 水平保持不变。减肥手术前 cfDNA 水平与 BFP 之间存在弱相关性,cfDNA 与 CRP 之间存在中度相关性。接受减肥手术的肥胖受试者,体脂百分比的下降并未导致手术后 6 个月 cfDNA 水平的变化。